Gyermekkori daganatok: vizsgálatok itt: Franciaország
209 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Bordeaux, Villejuif
- Életkor
- 6 hónap to 30 év
- People
- 65 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05533775 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Besançon, Marseille, Nantes, Paris, Pierre-Bénite, Strasbourg, Strasbourg Cedex 2, Toulouse, Tours, Vandoeuvre Les Nancy, Villejuif
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - No phaseTaking peopleIrradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
- Where
- Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris, Rennes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 6 év to 14 év
- People
- 130
- Run by
- Institut Claudius Regaud
See details and how to joinNCT06599879 - 2/3. fázisTaking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Creteil Cedex, Dijon, Lille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Rennes Cedex 9, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
- People
- 1541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Villejuif
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1/2. fázisTaking peopleA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
- Életkor
- 1 hónap to 17 év
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891 - 1. fázisTaking peoplePhase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Where
- Marseille, Villejuif
- Életkor
- 24 hónap to 18 év
- People
- 20 worldwide
- Run by
- ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00 - No phaseTaking peopleAQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
- Where
- Saint-Affrique
- People
- 120
- Run by
- AstraZeneca
See details and how to joinNCT06548152 - No phaseTaking peopleMenin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia
- Where
- Strasbourg
- Életkor
- 0 év to 17 év
- People
- 10
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07898436 - 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 3. fázisTaking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble, La Réunion, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - No phaseTaking peopleCharacterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
- Where
- Strasbourg
- Életkor
- 1 év and over
- People
- 50
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07895901 - No phaseTaking peopleRegistry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
- Where
- Vandœuvre-lès-Nancy
- People
- 3000
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT03410394 - 3. fázisTaking peopleInternational study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Where
- Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, Saint-Denis, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villejuif
- Életkor
- Up to 17 év
- People
- 137 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501454-11-00 - 3. fázisTaking peopleBiological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Where
- Amiens Cedex 1, Angers, Besançon, Bobigny, Bordeaux, Bordeaux Cedex, Brest, Bron, Caen, Caen Cedex 5, Clermont-Ferrand, Clichy, Dijon, Grenoble Cedex 9, La Réunion., La Tronche, Le Kremlin Bicetre Cedex, Lille, Limoges, Lyon, Marseille, Metz Cedex 03, Montpellier, Montpellier Cedex 5, Nancy, Nice, NICE, Nice Cedex 2, Paris, Pessac, Poitiers, Reims Cedex, Rennes, Rennes Cedex, Rouen Cedex, Saint-Denis, Saint-Herblain Cedex, Saint-Pierre, Saint-Pierre Cedex, Saint-Priest-en-Jarez, STRASBOURG, Alsace, Strasbourg Cedex 2, Suresnes, Toulouse, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Vandouvre Les Nancy, Villejuif
- Életkor
- 6 hónap and over
- People
- 433 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Amiens Cedex 1, Angers, Bayonne, Caen Cedex 9, Le Chesnay Rocquencourt, Le Mans, Lille Cedex, Limoges Cedex 1, Marseille, Nice, Paris, Pessac, Pierre-Bénite, Rouen Cedex, Strasbourg Cedex 2
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 3. fázisNot yet taking people in FranciaországComparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
- Where
- Villejuif
- Életkor
- Up to 5 év
- People
- 96 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT07291102 · EU 2024-517133-40-00 - 2/3. fázisNot yet taking people in FranciaországFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Paris
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisBefejeződöttA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Where
- Lille, Paris, Pessac
- People
- 115 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Amiens Cedex 1, Besancon Cedex, Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 2. fázisTaking peopleAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Where
- Lille, Lyon, Marseille, Strasbourg Cedex 2
- Életkor
- Up to 19 év
- People
- 232 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse Cedex 9
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Paris, Pessac, Pierre-Bénite, Villejuif
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00